Search research articles
Contact Us
Filters
Showing results (401-410 of 489) with videos related to
Page
of 49
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
JACC. Cardiovascular Imaging
|
January 4, 2023
Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance
Benedikt Bernhard, Aaron Schnyder, Davide Garachemani, et al.
Seminars in Oncology
|
September 11, 1999
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
JAMA Oncology
|
August 9, 2019
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
Nancy Y Yu, Adina Iftimi, Christina Yau, et al.
European Radiology
|
December 8, 2022
Impact of deep learning image reconstructions (DLIR) on coronary artery calcium quantification
Alexia Rossi, Antonio G Gennari, Dominik Etter, et al.
Oncotarget
|
June 28, 2014
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth
Kathleen A Wilson-Edell, Amanuel Kehasse, Gary K Scott, et al.
The International Journal of Cardiovascular Imaging
|
March 1, 2024
Prognostic value of visual and quantitative CMR regional myocardial function in patients with suspected myocarditis
Benedikt Bernhard, Philippe Joss, Noah Greisser, et al.
BBA Clinical
|
December 18, 2015
A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population
Eldon R Jupe, Kathie M Dalessandri, John J Mulvihill, et al.
JAMA Oncology
|
June 30, 2017
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
Laura J Esserman, Christina Yau, Carlie K Thompson, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial
Annelie Johansson, Huma Dar, Anna Nordenskjöld, et al.
Page
of 49
Search research articles
Search
Showing results (401-410 of 489) with videos related to
Sort By:
Page
of 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
JACC. Cardiovascular Imaging
|
January 4, 2023
Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance
Benedikt Bernhard, Aaron Schnyder, Davide Garachemani, et al.
Seminars in Oncology
|
September 11, 1999
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
JAMA Oncology
|
August 9, 2019
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
Nancy Y Yu, Adina Iftimi, Christina Yau, et al.
European Radiology
|
December 8, 2022
Impact of deep learning image reconstructions (DLIR) on coronary artery calcium quantification
Alexia Rossi, Antonio G Gennari, Dominik Etter, et al.
Oncotarget
|
June 28, 2014
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth
Kathleen A Wilson-Edell, Amanuel Kehasse, Gary K Scott, et al.
The International Journal of Cardiovascular Imaging
|
March 1, 2024
Prognostic value of visual and quantitative CMR regional myocardial function in patients with suspected myocarditis
Benedikt Bernhard, Philippe Joss, Noah Greisser, et al.
BBA Clinical
|
December 18, 2015
A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population
Eldon R Jupe, Kathie M Dalessandri, John J Mulvihill, et al.
JAMA Oncology
|
June 30, 2017
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
Laura J Esserman, Christina Yau, Carlie K Thompson, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial
Annelie Johansson, Huma Dar, Anna Nordenskjöld, et al.
Page
of 49